Unproven and expensive may still be justifiable

American Journal of Respiratory and Critical Care Medicine

Volumn 198, Issue 1, 2018, Pages 140-

  Abrams, Darryl ^a   Fan, Eddy ^b   Ferguson, Niall D ^b   Brodie, Daniel ^a  

^a College of Physicians and Surge ^*  (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT RESPIRATORY DISTRESS SYNDROME; EXTRACORPOREAL OXYGENATION; GAS EXCHANGE; HUMAN; LETTER; LUNG VENTILATION; PRIORITY JOURNAL; PRONE POSITION; DYSPNEA; PATIENT POSITIONING;

DYSPNEA; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; PATIENT POSITIONING; PRONE POSITION; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 85049694214     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201801-0112LE     Document Type: Letter

References (6)

1. Li X, Scales DC, Kavanagh BP. Unproven and expensive before proven and cheap: Extracorporeal membrane oxygenation versus prone position in ARDS. Am J Respir Crit Care Med 2018;197:991-993.
2. Guérin C, Beuret P, Constantin JM, Bellani G, Garcia-Olivares P, Roca O, et al.; Investigators of the APRONET Study Group, the REVA Network, the Réseau recherche de la Société Française d'Anesthésie-Réanimation (SFAR-recherche) and the ESICM Trials Group. A prospective international observational prevalence study on prone positioning of ARDS patients: The APRONET (ARDS Prone Position Network) study. Intensive Care Med 2018;44:22-37.
3. Brodie D, Guérin C. Rescue therapy for refractory ARDS should be offered early: no. Intensive Care Med 2015;41:926-929.
4. Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al.; LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016;315: 788-800.
5. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al.; CESAR trial collaboration. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A multicentre randomised controlled trial. Lancet 2009;374:1351-1363.
6. Abrams D, Brodie D. Extracorporeal membrane oxygenation is first-line therapy for acute respiratory distress syndrome. Crit Care Med 2017; 45:2070-2073.